Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Exploring Potential Molecular Mechanisms of Drug Response in FLT3-ITD Negative AML Patients Treated with Quizartinib Vs Placebo Plus Standard Chemotherapy in the Quiwi Trial

Blood (2023) 142 (Supplement 1): 6037.

https://doi.org/10.1182/blood-2023-180710

Published: 2023

Journal Articles

The FLT3-like Gene Expression Signature Predicts Response to Quizartinib in Wild-Type FLT3 Acute Myeloid Leukemia: An Analysis of the Pethema Quiwi Trial

Blood (2023) 142 (Supplement 1): 974.

https://doi.org/10.1182/blood-2023-180482

Published: 2023

Journal Articles

Clinical Features and Treatment in Patients Diagnosed with Blastic Plasmacytoid Dendritic Cell Neoplasm: Interim Analysis from the Pethema Epidemiologic Registry (EPI-BLAS study)

Blood (2023) 142 (Supplement 1): 4234.

https://doi.org/10.1182/blood-2023-190296

Published: 2023

Journal Articles

Prognostic Impact of NPM1 and FLT3 -ITD Mutations in Patients Treated with Non-Intensive Regimens: A Pethema Registry Study

Blood (2022) 140 (Supplement 1): 6077–6079.

https://doi.org/10.1182/blood-2022-167365

Published: 2022

Journal Articles

Patterns of Salvage Therapy in Patients with Acute Myeloid Leukemia Treated Upfront with Azacitidine or Decitabine: Results from the Pethema AML Registry

Blood (2021) 138 (Supplement 1): 1255.

https://doi.org/10.1182/blood-2021-150544

Published: 2021

Journal Articles

Long-Term Subgroup Analyses from Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry

Blood (2021) 138 (Supplement 1): 1256.

https://doi.org/10.1182/blood-2021-150649

Published: 2021

Journal Articles

Nationwide Laboratory Network for AML Cross-Validated NGS Studies: Results from a Real-Life Cohort of the Pethema Group

Blood (2021) 138 (Supplement 1): 1302.

https://doi.org/10.1182/blood-2021-152353

Published: 2021

Journal Articles

Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry

Blood (2020) 136 (Supplement 1): 25–27.

https://doi.org/10.1182/blood-2020-141213

Published: 2020

Journal Articles

The Complete Mutatome and Clonal Architecture of Del(5q)

Vera Ademà, MSc, Laura Palomo, MSc, Przychodzen P Bartlomiej, Diez-campelo Maria, MD, Naoko Hosono, MD PhD, Mar Mallo, PhD, Blanca Xicoy, MD PhD, Elisa Luño, Bhumika J. Patel, Cassandra M Hirsch, Lurdes Zamora, PhD, Thomas LaFramboise, PhD, Leonor Arenillas, MD, Albert Perez-Ladaga, PhD, Carme Pedro, Michael J. Clemente, Joan Bargay, MD, Julia Montoro, MD, Juan Carlos Caballero, MD, Brayan Merchan, MD, Victor Noriega, MD, Victor Marcos-Betes, MD, Consuelo Del Cañizo, MD PhD, Rosario Lopez, PhD, José María Raya, MD, Joaquin Sanchez-Garcia, MD, Eduardo Rios, Montserrat Arnan, MD PhD, Lourdes Florensa, MD PhD, Raquel de Paz, Angelina Lemes, MD, Paula Gomez-Marzo, MSc, Nuri Haro, Francisco Fuster-Tormo, MSc, Monica Bayes, PhD, Ivo Gut, Rafael Bejar, MDPhD, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD, Francesc Sole, PhD

Blood (2015) 126 (23): 608.

https://doi.org/10.1182/blood.V126.23.608.608

Published: 2015

Journal Articles

Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma: A Retrospective Study of the Geltamo Group (1994-2011)

Blood (2014) 124 (21): 3980.

https://doi.org/10.1182/blood.V124.21.3980.3980

Published: 2014

Journal Articles

BK Virus (BKV) Associated Haemorrhagic Cystitis Is Associated with Graft Versus Host Disease (GVHD) and Significant Morbidity Post Haematopoietic Stem Cell Transplant (HSCT).

Alesia Abigael Hunt, MBChB MRCP, Anjum Bashir Khan, MBChB, MRCP, Donal McLornan, MD, PhD, Majid A Kazmi, BmedBiol MB ChB MRCP(UK) MRCPath, Matthew Streetly, BMBS, MRCP, MRCPath, Victor Noriega, MD, Eithne MacMahon, Kavita Raj, MD, PhD, MRCP, FRCPath

Blood (2012) 120 (21): 3040.

https://doi.org/10.1182/blood.V120.21.3040.3040

Published: 2012

Journal Articles

Adverse Effect of Very Poor Cytogenetics and Monosomal Karyotype On Outcomes Following T-Deplete Reduced Intensity Conditioned Stem Cell Transplant for MDS and AML.

Pramila Krishnamurthy, MA MRCP FRCPath, Victoria T Potter, MBBS, FRCPA, FRACP, Austin G Kulasekararaj, Victor Noriega, Hugues de Lavallade, Robin M. Ireland, FRCP, FRCPath, Stephen Devereux, FRCP, FRCPath, Judith C. W. Marsh, MD, PhD, Robert E. Marcus, MBBS, FRCP, FRCPath, Barbara Czepulkowski, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J. Mufti, MD

Blood (2012) 120 (21): 3141.

https://doi.org/10.1182/blood.V120.21.3141.3141

Published: 2012

Journal Articles

Allogeneic Stem Cell Transplantation for Accelerated/Blastic Phase Philadelphia-Chromosome Negative MPN

Anjum Bashir Khan, MBChB, MRCP, Donal McLornan, MD, PhD, Yogesh Jethava, MB, MRCP, MD, FRCPath, Kavita Raj, MD, PhD, MRCP, FRCPath, Victoria T Potter, MBBS, FRCPA, FRACP, Hugues de Lavallade, MD, Majid A Kazmi, BmedBiol MB ChB MRCP (UK) MRCPath, ZiYi Lim, MD, Judith C. W. Marsh, Prof MD PhD, Sangeeta Atwal, MBBS MRCP FRCPath, Victor Noriega, MD, Claire N Harrison, DM FRCP FRCPath, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J. Mufti, MD

Blood (2012) 120 (21): 4532.

https://doi.org/10.1182/blood.V120.21.4532.4532

Published: 2012

Journal Articles

Demethylating Agents As a Salvage Treatment in Relapsed Myeloid Diseases Following Allogeneic Bone Marrow Transplantation

Sangeeta Atwal, MBBS, MRCP, FRCPath, Anjum Bashir Khan, MBChB, MRCP, Victor Noriega, MD, Yogesh Jethava, MB, MRCP, MD, FRCPath, Michelle Kenyon, BSc, RN, Hugues de Lavallade, MD, Donal McLornan, MD, PhD, Victoria T Potter, MBBS, FRCPA, FRACP, Kavita Raj, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J. Mufti, MD

Blood (2012) 120 (21): 4216.

https://doi.org/10.1182/blood.V120.21.4216.4216

Published: 2012

Journal Articles

Outcome of BEAM-Autologous and BEAM-Alemtuzumab Allogeneic Transplantation in Relapsed Advanced Stage Follicular Lymphoma

Victor Noriega, MD, Anjum Bashir Khan, MBChB, MRCP, Stephen Devereux, FRCP, FRCPath, PhD, Robert E. Marcus, MBBS, FRCP, FRCPath, Michelle Kenyon, Victoria T Potter, MBBS, FRCPA, FRACP, Ghulam J Mufti, FRCP, FRCPath, M.D., Antonio Pagliuca, MBBS, FRCP, FRCPath, MA

Blood (2012) 120 (21): 2022.

https://doi.org/10.1182/blood.V120.21.2022.2022

Published: 2012

Journal Articles

Usefulness of the Quantitative Follow-up of Chimerism in Cell-Free Plasma DNA for the Prediction/Early Diagnosis of Complications After Hematopoietic Stem Cell Transplantation

Carolina Martinez-Laperche, PhD, Victor Noriega, MD, Leyre Bento, MD, Milagros Gonzalez-Rivera, MD, PhD, Pascual Balsalobre, MSc, Mi Kwon, MD, David Serrano, MD, Jorge Gayoso, MD, Jose L. Diez-Martin, MD, PhD, Ismael Buno, PhD

Blood (2012) 120 (21): 4146.

https://doi.org/10.1182/blood.V120.21.4146.4146

Published: 2012

Journal Articles

HCT-CI Is Not a Useful Predictor for Non Relapse Mortality in Older Patients (>60 years old) Receiving RIC Transplant for AML or MDS

Victor Noriega, MD, Hugues de Lavallade, MD, Victoria T Potter, MBBS, FRCPA, FRACP, Pramila Krishnamurthy, Judith C. W. Marsh, Prof MD PhD, Stephen Devereux, FRCP, FRCPath, Ph.D., Robert E. Marcus, MBBS, FRCP, FRCPath, Kavita Raj, Donal McLornan, MD, PhD, Anjum Bashir Khan, MBChB, MRCP, Sangeeta Atwal, MBBS MRCP FRCPath, Robin M. Ireland, FRCP, FRCPath, Deborah Yallop, BSc, FRCPath, MB, BS, MRCP, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J Mufti, FRCP, FRCPath, M.D.

Blood (2012) 120 (21): 4158.

https://doi.org/10.1182/blood.V120.21.4158.4158

Published: 2012

Journal Articles

The Genotype in the Donor and Recipient for the Polymorphim −174 G/C of the IL-6 Influences the Outcome of HLA-Identical Related Stem Cell Transplantation,

Blood (2011) 118 (21): 4082.

https://doi.org/10.1182/blood.V118.21.4082.4082

Published: 2011

Journal Articles

The Genotype of the Donor for the (GT) n Polymorphism in the Promoter/Enhancer of the FOXP3 Gene Influences Graft Versus Host Disease without Affecting Graft Versus Leukemia Effect After Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation

Victor Noriega, Carolina Martinez-Laperche, Leyre Bento, Noemi Sanchez-Hernandez, Milagros Gonzalez-Rivera, Pascual Balsalobre, Mi Kwon, Jorge Gayoso, Jose Luis Diez-Martin, Ismael Buno

Blood (2011) 118 (21): 3051.

https://doi.org/10.1182/blood.V118.21.3051.3051

Published: 2011

NARROW

Exploring Potential Molecular Mechanisms of Drug Response in FLT3-ITD Negative AML Patients Treated with Quizartinib Vs Placebo Plus Standard Chemotherapy in the Quiwi Trial

The FLT3-like Gene Expression Signature Predicts Response to Quizartinib in Wild-Type FLT3 Acute Myeloid Leukemia: An Analysis of the Pethema Quiwi Trial

Clinical Features and Treatment in Patients Diagnosed with Blastic Plasmacytoid Dendritic Cell Neoplasm: Interim Analysis from the Pethema Epidemiologic Registry (EPI-BLAS study)

Prognostic Impact of NPM1 and FLT3 -ITD Mutations in Patients Treated with Non-Intensive Regimens: A Pethema Registry Study

Patterns of Salvage Therapy in Patients with Acute Myeloid Leukemia Treated Upfront with Azacitidine or Decitabine: Results from the Pethema AML Registry

Long-Term Subgroup Analyses from Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry

Nationwide Laboratory Network for AML Cross-Validated NGS Studies: Results from a Real-Life Cohort of the Pethema Group

Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry

The Complete Mutatome and Clonal Architecture of Del(5q)

Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma: A Retrospective Study of the Geltamo Group (1994-2011)

BK Virus (BKV) Associated Haemorrhagic Cystitis Is Associated with Graft Versus Host Disease (GVHD) and Significant Morbidity Post Haematopoietic Stem Cell Transplant (HSCT).

Adverse Effect of Very Poor Cytogenetics and Monosomal Karyotype On Outcomes Following T-Deplete Reduced Intensity Conditioned Stem Cell Transplant for MDS and AML.

Allogeneic Stem Cell Transplantation for Accelerated/Blastic Phase Philadelphia-Chromosome Negative MPN

Demethylating Agents As a Salvage Treatment in Relapsed Myeloid Diseases Following Allogeneic Bone Marrow Transplantation

Outcome of BEAM-Autologous and BEAM-Alemtuzumab Allogeneic Transplantation in Relapsed Advanced Stage Follicular Lymphoma

Usefulness of the Quantitative Follow-up of Chimerism in Cell-Free Plasma DNA for the Prediction/Early Diagnosis of Complications After Hematopoietic Stem Cell Transplantation

HCT-CI Is Not a Useful Predictor for Non Relapse Mortality in Older Patients (>60 years old) Receiving RIC Transplant for AML or MDS

The Genotype in the Donor and Recipient for the Polymorphim −174 G/C of the IL-6 Influences the Outcome of HLA-Identical Related Stem Cell Transplantation,

The Genotype of the Donor for the (GT) n Polymorphism in the Promoter/Enhancer of the FOXP3 Gene Influences Graft Versus Host Disease without Affecting Graft Versus Leukemia Effect After Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only